Oncotarget

Research Papers:

miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin

Wen-Shu Chen _, Chia-Jui Yen, Yun-Ju Chen, Jhen-Yu Chen, Li-Yun Wang, Shu-Jun Chiu, Wen-Ling Shih, Chien-Yi Ho, Tzu-Tang Wei, Hsiao-Lin Pan, Pei-Hsuan Chien, Mien-Chie Hung, Ching-Chow Chen and Wei-Chien Huang

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2015; 6:25962-25974. https://doi.org/10.18632/oncotarget.4504

Metrics: PDF 2052 views  |   HTML 2745 views  |   ?  


Abstract

Wen-Shu Chen1,2,4,*, Chia-Jui Yen6,*, Yun-Ju Chen7,8, Jhen-Yu Chen2,4,5, Li-Yun Wang2,4, Shu-Jun Chiu9,10, Wen-Ling Shih11, Chien-Yi Ho3, Tzu-Tang Wei1, Hsiao-Lin Pan7, Pei-Hsuan Chien7, Mien-Chie Hung2,4,12, Ching-Chow Chen1, Wei-Chien Huang2,4,5,13

1Department of Pharmacology, National Taiwan University, Taipei, Taiwan

2Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan

3Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan

4Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan

5The Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University, Taichung, Taiwan

6Internal Medicine, National Cheng-Kung University, Tainan, Taiwan

7Department of Medical Research, E-Da Hospital, Kaohsiung, Taiwan

8Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan

9Department of Life Sciences, Tzu Chi University, Hualien, Taiwan

10Institute of Radiation Sciences, Tzu Chi Technology College, Hualien, Taiwan

11Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung, Taiwan

12Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

13Department of Biotechnology, Asia University, Taichung, Taiwan

*These authors have contributed equally to this work

Correspondence to:

Wei-Chien Huang, e-mail: [email protected]

Ching-Chow Chen, e-mail: [email protected]

Mien-Chie Hung, e-mail: [email protected]

Keywords: HBx, microRNA, maspin, hepatocellular carcinoma cell, metastasis

Received: May 19, 2015     Accepted: July 06, 2015     Published: July 17, 2015

ABSTRACT

Maspin suppresses tumor progression by promoting cell adhesion and apoptosis and by inhibiting cell motility. However, its role in tumorigenesis of hepatocellular carcinoma (HCC) remains unclear. The gene regulation of maspin and its relationship with HCC patient prognosis were investigated in this study. Maspin expression was specifically reduced in HBV-associated patients and correlated with their poor prognosis. Maspin downregulation in HCC cells was induced by HBx to promote their motility and resistance to anoikis and chemotherapy. HBx-dependent induction of microRNA-7, -107, and -21 was further demonstrated to directly target maspin mRNA, leading to its protein downregulation. Higher expressions of these microRNAs also correlated with maspin downregulation in HBV-associated patients, and were associated with their poor overall survival. These data not only provided new insights into the molecular mechanisms of maspin deficiency by HBx, but also indicated that downregulation of maspin by microRNAs confers HBx-mediated aggressiveness and chemoresistance in HCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 4504